Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Endogenous peptide; FPRL1/2 agonist.
G6PDH inhibitor.
Podophyllotoxin derivative found in Podophyllum...
p53 activator.
Fluoroquinolone; vacuolar H+ ATPase, topoisomer...
ATP-sensitive K+ channel activator, α-adrenerg...
Isoflavone found in soy; SERM.
Cephalomannine derivative found in Taxus; poten...
ATM and ATR inhibitor.
ALK inhibitor.
Bumetanide impurity
Peptide, binds fibronectin.
CRTH2 inhibitor, TxA2 antagonist.
Neuroprotective flavonoid
Nitrosourea, DNA alkylator.
Topoisomerase II inhibitor, RPA modulator.
AChE and BChE inhibitor.
Naturally occurring sesteterpenoid.
Vitamin D, calcitriol prodrug; VDR agonist.
SIRT1/2 inhibitor, indirect p53 activator.